Literature DB >> 8425948

The association of potentially lethal neurologic syndromes with scleromyxedema (papular mucinosis).

G F Webster1, L Y Matsuoka, D Burchmore.   

Abstract

Two patients with scleromyxedema who had progressive neurologic impairment are described. One patient died, and one required prolonged mechanical ventilation. A review of the literature has produced 24 other cases of scleromyxedema in which neurologic changes were prominent.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8425948     DOI: 10.1016/0190-9622(93)70021-k

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

1.  [Scleromyxedema. A chronic progressive systemic disease].

Authors:  A Kreuter; M Stücker; A G A Kolios; P Altmeyer; K Möllenhoff
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

Review 2.  New insights on scleromyxedema.

Authors:  Laura Atzori; Caterina Ferreli; Franco Rongioletti
Journal:  J Scleroderma Relat Disord       Date:  2019-01-29

Review 3.  Scleroderma-like fibrosing disorders.

Authors:  Francesco Boin; Laura K Hummers
Journal:  Rheum Dis Clin North Am       Date:  2008-02       Impact factor: 2.670

4.  [Differential diagnose of angioedema. Acute edematous scleromyxedema].

Authors:  S Gerstner; H Kneitz; E-B Bröcker; A Trautmann
Journal:  Hautarzt       Date:  2014-05       Impact factor: 0.751

5.  Immunohistochemical investigations and introduction of new therapeutic strategies in scleromyxoedema: case report.

Authors:  Frank Breuckmann; Marcus Freitag; Sebastian Rotterdam; Markus Stuecker; Peter Altmeyer; Alexander Kreuter
Journal:  BMC Dermatol       Date:  2004-09-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.